Involvement of nitric oxide in anticompulsive-like effect of agmatine on marble-burying behaviour in mice

European Journal of Pharmacology

Volumn 770, Issue , 2016, Pages 165-171

  Gawali, Nitin B ^a   Chowdhury, Amrita A ^a   Kothavade, Pankaj S ^a   Bulani, Vipin D ^a   Nagmoti, Dnyaneshwar M ^a   Juvekar, Archana R ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Agmatine; Marble burring behaviour; Nitric oxide; Obsessive compulsive disorder

Indexed keywords

7 NITROINDAZOLE; AGMATINE; ARGININE; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE INHIBITOR; NITRIC OXIDE; NITRITE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; 7-NITROINDAZOLE; CALCIUM CARBONATE; INDAZOLE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOMPULSIVE LIKE EFFECT; ARTICLE; BRAIN HOMOGENATE; COMORBIDITY; CONTROLLED STUDY; DRUG ACTIVITY; DSM-IV-TR; HIPPOCAMPUS; INCIDENCE; LOCOMOTION; MALE; MARBLE BURYING BEHAVIOR; MOTOR ACTIVITY; MOUSE; NITRERGIC NERVE; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; CLASSIFICATION; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; OBSESSIVE-COMPULSIVE DISORDER;

AGMATINE; ANIMALS; ARGININE; BEHAVIOR, ANIMAL; BRAIN; CALCIUM CARBONATE; DOSE-RESPONSE RELATIONSHIP, DRUG; INDAZOLES; MALE; MICE; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84952879798     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.11.044     Document Type: Article

References (62)

1. K. Abe, Y. Abe, and H. Saito Agmatine suppresses nitric oxide production in microglia Brain Res. 872 2000 141 148
2. J. Angulo, C. Peiro, C.F. Sanchez-Ferrer, S. Gabancho, P. Cuevas, S. Gupta, and I. Sáenz de Tejada Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue Br. J. Pharmacol. 134 2001 1190 1194
3. F. Aricioglu, and H. Altunbas Is agmatine an endogenous anxiolytic/antidepressant agent? Ann. N. Y. Acad. Sci. 1009 2003 136 140
4. M. Atmaca, E. Tezcan, M. Kuloglu, and B. Ustundag Plasma nitrate values in patients with obsessive-compulsive disorder Psychiatry Clin. Neurosci. 59 2005 621 623
5. M. August, I. Viossat, J.G. Marin, and P.E. Chabrier Selective inhibition of inducible nitric oxide synthase by agmatine Jpn. J. Pharmacol. 69 1995 285 287
6. J.A. Bartz, and E. Hollander Is obsessive-compulsive disorder an anxiety disorder? Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 338 352
7. A.K. Bence, D.R. Worthen, J.P. Stables, and P.A. Crooks An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine Behav. Brain Res. 74 2003 771 775
8. S.F. De Boer, and J.M. Koolhaas Defensive burying in rodents: ethology, neurobiology and psychopharmacology Eur. J. Pharmacol. 463 2003 145 161
9. E.H. Decloedt, and D.J. Stein Current trends in drug treatment of obsessive compulsive disorder Neuropsychiatr. Dis. Treat. 6 2010 233 242
10. D.R. Demady, S. Jianmongkol, J.L. Vuletich, A.T. Bender, and Y. Osawa Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme Mol. Pharmacol. 59 1 2001 24 29
11. D. Denys, J. Zohar, and H.G. Westenberg The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence J. Clin. Psychiatry 65 2004 11 17
12. J.V. Esplugues NO as a signaling molecule in the nervous system Br. J. Pharmacol. 135 2002 1079 1095
13. D. Farzin, and N. Mansouri Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test Eur. Neuropsychopharmacol. 16 2006 324 328
14. F. Fujiyama, and S. Masuko Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum: an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry Brain Res. Bull. 40 1996 121 127
15. E. Galea, S. Ragunathan, V. Elipoulos, D.L. Feinstein, and D.J Reis Inhibition of mammalian nitric oxide synthase by agmatine, an endogenous polyamine decarboxylastion of arginine Biochem. J. 316 1996 247 249
16. J.A. García-Sevilla, P.V. Escribá, X. Busquets, C. Walzer, and J. Guimón Platelet imidazoline receptors and regulatory G proteins in patients with major depression Neuroreport 8 1996 169 172
17. Z.H. Gong, Y.F. Li, N. Zhao, H.J. Yang, R.B. Su, and Z.P. Luo Anxiolytic effect of agmatine in rats and mice Eur. J. Pharmacol. 550 2006 112 116
18. F.S. Guimaraes, V. Beijamini, F.A. Moreira, D.C. Aguiar, and A.B.C. De Lucca Role of nitric oxide in brain regions related to defensive reactions Neurosci. Biobehav. Rev. 29 2005 1313 1322
19. A. Halaris, H. Zhu, J. Ali, A. Nasrallah, C.L. De Vane, and J.E. Piletz Downregulation of platelet imidazoline-1-binding sites after bupropion treatment Int. J. Neuropsychopharmacol. 5 2002 37 46
20. A. Harkin, K.H. Bruce, B. Craft, and I.A. Paul Nitric oxide synthase inhibitors have antidepressant-like properties in mice: acute treatments are active in the forced swim test Eur. J. Pharmacol. 372 1999 207 213
21. A. Harkin, T.J. Connor, M. Walsh St., N. John, and J.P. Kelly Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors Neuropharmacology 44 2003 616 623
22. S. Hidaka, and S. Totterdell Ultrastructural features of the nitric oxide synthase containing interneurons in the nucleus accumbens and their relationship with tyrosine hydroxylase-containing terminals J. Comp. Neurol. 431 2001 139 154
23. S. Hoog A review of the validity and variability of the elevated plus-maze as an animal model of anxiety Pharmacol. Biochem. Behav. 54 1996 21 30
24. 1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice J. Pharmacol. 68 1995 65 70
25. D. Joel Current animal models of obsessive-compulsive disorder: a critical review Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 374 388
26. S.T. Kaehler, N. Singewald, C. Sinner, and A. Philippu Nitric oxide modulates the release of serotonin in the rat hypothalamus Brain Res. 835 2 1999 346 349
27. N.R. Kotagale, B.G. Taksande, P.J. Wadhwani, M.W. Palhade, S.M. Mendhi, D.Y. Gawande, P.N. Hadole, and C.T. Chopde Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents Pharmacol. Biochem. Behav. 100 2012 398 403
28. M. Krass, K. Runkorg, G. Wegener, and V. Volke Nitric oxide is involved in the regulation of marble-burying behavior Neurosci. Lett. 480 2010 55 58
29. N.S. Kwon, C.F. Nathan, C. Gilker, O.W. Griffith, D.E. Matthews, and D.J. Stuehr l-citrulline production from L-arginine by microphage nitric oxide syntheses J. Biol. Chem. 265 1990 13442 13445
30. D. Lavinsky, N. Sarmento, A. Carlos, and A. Netto Agmatine induces anxiolysisin the elevated plus maze task in adult rats Behav. Brain Res. 141 2003 19 24
31. Y.F. Li, Z.H. Gong, J.B. Cao, H.L. Wang, Z.P. Luo, and J. Li Antidepressant-like effect of agmatine and its possible mechanism Eur. J. Pharmacol. 469 2003 81 88
32. H.C. Lin, B.H. Kang, F.J. Wan, S.T. Huang, and C.J. Tseng Reciprocal regulation of nitric oxide and glutamate in the nucleus tractus solitarii of rats Eur. J. Pharmacol. 407 2000 83 89
33. T. Londei, A.M. Valentini, and V.G. Leone Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour Behav. Brain Res. 94 1998 249 254
34. L. Luo, and R.X. Tan Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model Acta Pharmacol. Sin. 22 2001 865 870
35. M.E. Mansari, and P. Blier Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 362 373
36. K. Montezuma, C. Biojone, S.F. Lisboa, F.Q. Cunha, F.S. Guimaraes, and S.R. Joca Inhibition of iNOS induces antidepressant like effects in mice: pharmacological and genetic evidence Neuropharmacology 62 1 2012 485 491
37. M.N. Nakashima, K. Ajiki, K. Nakashima, and M. Takahashi Possible role of nitric oxide in anxiety following transient cerebral ischemia in mice J. Pharm. Sci. 91 2003 47 52
38. K. Njunge, and S.L. Handley Evaluation of marble-burying behavior as a model of anxiety Pharmacol. Biochem. Behav. 38 1991 63 67
39. A. Okasha Diagnosis of obsessive-compulsive disorder: a review obsessive-compulsive disorder 2003 John Wiley & Sons, Ltd. Chichester, UK 1 41
40. G. Olmos, N. DeGregorio-Rocasolano, M. Paz Regalado, T. Gasull, M. Assumpcio Boronat, R. Trullas, A. Villarroel, and J. Lerma Protection by imidazoline drugs and agmatine of glutamate induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor Br. J. Pharmacol. 127 1999 1317 1326
41. A. Onal, Y. Delen, S. Ulker, and N. Soykan Agmatine attenuates neuropathic pain in rats: possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum Life Sci. 73 2004 413 428
42. K. Otake, D.A. Ruggiero, S. Regunathan, H. Wang, T.A. Milner, and D.J. Reis Regional localization of agmatine in the rat brain: an immunocytochemical study Brain. Res. 787 1998 1 14
43. W. Raasch, S. Regunathan, G. Li, and D.J. Reis Agmatine is widely and unequally distributed in rat organs Ann. N. Y. Acad. Sci. 763 1995 330 334
44. D.J. Reis, and S. Regunathan Is agmatine a novel neurotransmitter in brain? Trends Pharmacol. Sci. 21 2000 187 193
45. Y. Sasson, J. Zohar, M. Chopra, M. Lustig, I. Iancu, and T. Hendler Epidemiology of obsessive-compulsive disorder: a world view J. Clin. Psychiatry 58 12 1997 7 10
46. J. Segieth, B. Pearce, L. Fowler, and P.S. Whitton Regulatory role of nitric oxide over hippocampal 5-HT release in vivo Naunyn Schmiedebergs Arch. Pharmacol. 363 2001 302 306
47. P.A. Serra, G. Rocchitta, G. Esposito, M.R. Delogu, R. Migheli, E. Miele, M.S. Desole, and M. Miele A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats Br. J. Pharmacol. 134 2001 275 282
48. J.C. Smith, and P.S. Whitton Nitric oxide modulates N-methyl-d-aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat Neurosci. Lett. 291 2000 5 8
49. P.C. Spolidorio, M.B. Echeverry, M. Iyomasa, F.S. Guimaraes, and E.A. Del Bel Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus Psychopharmacology 195 2007 183 192
50. B.G. Taksande, N.R. Kotagale, S.J. Tripathi, R.R. Ugale, and C.T. Chopde Antidepressant like effect of selective serotonin reuptake inhibitors involves modulation of imidazoline receptors by agmatine Neuropharmacology 57 2009 415 424
51. B.G. Taksande, N.R. Kotagale, M.R. Patel, G.P. Shelkar, R.R. Ugale, and C.T. Chopde Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats Eur. J. Pharmacol. 637 2010 89 101
52. W.R. Tracey, J. Tse, and G. Carter Lipopolysaccharide induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors J. Pharmacol. Exp. Ther. 282 3 1995 1011 1015
53. S.N. Umathe, J.M. Vaghasiya, N.S. Jain, and P.V. Dixit Neurosteroids modulate compulsive and persistent behavior in rodents: Implications for obsessive-compulsive disorder Prog. Neuropsychopharmacol. Biol. Psychiatry 33 2009 1161 1166
54. T.I. Uzbay The pharmacological importance of agmatine in the brain Neurosci. Biobehav. Rev. 36 1 2012 502 519
55. V. Volke, A. Soosar, S. Koks, M. Bourin, P.T. Mannisto, and E. Vasar 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety Psychopharmacol 131 1997 399 405
56. G. Wegener, B.H. Harvey, B. Bonefeld, H.K. Müller, V. Volke, D.H. Overstreet, and B. Elfving Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression Int. J. Neuropsychopharmacol. 13 2010 461 473
57. G. Wegener, V. Volke, B.H. Harvey, and R. Rosenberg Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity Brain Res. 959 2003 128 134
58. G. Wegener, V. Volke, and R. Rosenberg Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo Br. J. Pharmacol. 130 2000 575 580
59. A.R. West, and M.P. Galloway Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms Neurochem. Int. 33 1998 493 501
60. M.P. Zeidan, A.D. Zomkowski, A.O. Rosa, A.L. Rodrigues, and N.H. Gabilan Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test Eur. J. Pharmacol. 565 2007 125 131
61. H. Zhu, A. Halaris, S. Madakasira, P. Pazzaglia, N. Goldman, C.L. DeVane, M. Andrew, D. Reis, and J.E. Piletz Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients J. Psychiatr. Res. 33 1999 323 333
62. A.D.E. Zomkowski, L. Hammes, J. Lin, J.B. Calixto, A.R.S. Santos, and A.L.S. Rodrigues Agmatine produces antidepressant-like effects in two models of depression in mice Neuroreport 13 2002 387 391